Unassociated Document

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 8-K

Current Report 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

September 30, 2004
Date of Report
 (Date of earliest event reported)


RITA Medical Systems, Inc.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of incorporation)

 000-30959

 94-3199149

 (Commission File Number)

 (I.R.S. Employer Identification No.)

 
967 N. Shoreline Blvd.
Mountain View, CA 94043
(Address of principal executive offices, with zip code)

(650) 314-3400
(Registrant's telephone number, including area code)

     
 
 


Item 8.01. Other Events and Required FD Disclosure.

On September 30, 2004, RITA Medical Systems, Inc., a Delaware corporation (“RITA”), announced that Mr. Joseph DeVivo, RITA’s President and CEO, made a presentation at the UBS conference in New York City. Mr. DeVivo’s slides are attached to this 8K filing.
 
 
 



 
     
 



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


RITA Medical Systems, Inc.



Date: September 30, 2004        By: /s/ Donald Stewart                                          
Donald Stewart, Chief Financial Officer and
Vice President Finance and Administration

 
 

 

 
     
 
 



RITA MEDICAL SYSTEMS, INC.
INDEX TO EXHIBITS


Exhibit Number
Description
 
     
99.1
Press Release of RITA Medical Systems, Inc. dated September 30, 2004.